SCHEMBL13745279

SCHEMBL13745279

CN(CC(=O)OC(C)(C)C)NC(=O)NCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPID Q08752 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.46
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA7 P43166 1/20 0.44
CA14 Q9ULX7 1/20 0.44
RIPK1 Q13546 1/20 0.43
MAPT P10636 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CTSL P07711 1/20 0.43
CTSB P07858 1/20 0.43
CTSS P25774 1/20 0.43
AKT1 P31749 2/20 0.42
EPHX1 P07099 1/20 0.42
ALDH1A1 P00352 2/20 0.42
CTSK P43235 2/20 0.42
TP53 P04637 2/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13745661 0.85 PPID (0.47) PPIDSMN1; SMN2CA12CA1CA7
SCHEMBL1285009 0.83 PPID (0.64) PPIDSMN1; SMN2MAPTL3MBTL1EPHX1
SCHEMBL1285838 0.82 SMN1; SMN2 (0.54) PPIDSMN1; SMN2MAPTL3MBTL1EPHX1
SCHEMBL4254554 0.81 PPID (0.48) PPIDSMN1; SMN2CA12CA1CA7
SCHEMBL23804464 0.81 PPID (0.43) PPIDSMN1; SMN2CA12CA1CA7
SCHEMBL6988810 0.80 PPID (0.68) PPIDSMN1; SMN2CA12CA1CA7
SCHEMBL13745015 0.79 RAB9A (0.46) PPIDSMN1; SMN2AKT1ALDH1A1TP53
SCHEMBL14255755 0.77 EPHX1 (0.56) PPIDSMN1; SMN2CA12CA1CA7
SCHEMBL4256142 0.76 AKT1 (0.45) PPIDSMN1; SMN2CA12CA1CA7
SCHEMBL22649519 0.76 AKT1 (0.54) PPIDSMN1; SMN2CA12CA1CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215783-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION CHOONGWAE PHARMA CORPORATION (KR) 2009-08-27 US disclosed
US-20090215783-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION CHOONGWAE PHARMA CORPORATION (KR) 2009-08-27 US disclosed
WO-2007139346-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION CHOONGWAE PHARMA CORPORATION (KR) 2007-12-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215783-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION MYLK2, TNNC1, MYH2 PPID 975/4885SMN1; SMN2 103/4885CA12 3213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.